We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLPH
1251
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$298K ﹤0.01%
8,200
+6,667
+435% +$231K
ALPN
1252
DELISTED
Alpine Immune Sciences Inc
ALPN
$293K ﹤0.01%
38,750
IVTY
1253
DELISTED
Invuity, Inc
IVTY
$293K ﹤0.01%
75,000
META icon
1254
Meta Platforms (Facebook)
META
$1.42T
$291K ﹤0.01%
1,500
MSN icon
1255
Emerson Radio
MSN
$7.79M
$289K ﹤0.01%
198,100
ASFI
1256
DELISTED
Asta Funding Inc
ASFI
$288K ﹤0.01%
83,600
-38,500
-32% -$138K
ESP icon
1257
Espey Mfg & Electronics Corp
ESP
$177M
$287K ﹤0.01%
10,700
SENS icon
1258
Senseonics Holdings Inc
SENS
$263M
$287K ﹤0.01%
3,494
-6,742
-66% -$483K
IWO icon
1259
iShares Russell 2000 Growth ETF
IWO
$14.3B
$286K ﹤0.01%
+1,400
New +$280K
TTPH
1260
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$285K ﹤0.01%
3,990
MTZ icon
1261
MasTec
MTZ
$21.1B
$284K ﹤0.01%
5,600
-9,600
-63% -$464K
AXSM icon
1262
Axsome Therapeutics
AXSM
$11.2B
$282K ﹤0.01%
88,000
AMS icon
1263
American Shared Hospital Services
AMS
$9.94M
$279K ﹤0.01%
101,400
XTNT icon
1264
Xtant Medical Holdings
XTNT
$60.3M
$278K ﹤0.01%
+50,000
New +$334K
DVD
1265
DELISTED
Dover Motorsports
DVD
$278K ﹤0.01%
123,396
NHLD
1266
DELISTED
National Holdings Corporation
NHLD
$278K ﹤0.01%
84,400
+23,100
+38% +$82.6K
TRT
1267
Trio-Tech International
TRT
$101M
$275K ﹤0.01%
123,200
RLJE
1268
DELISTED
RLJ Entertainment, Inc.
RLJE
$271K ﹤0.01%
58,600
AMTX icon
1269
Aemetis
AMTX
$106M
$269K ﹤0.01%
178,239
JOE icon
1270
St. Joe Company
JOE
$3.54B
$269K ﹤0.01%
15,000
KRO icon
1271
KRONOS Worldwide
KRO
$693M
$268K ﹤0.01%
11,900
PBIP
1272
DELISTED
Prudential Bancorp, Inc.
PBIP
$268K ﹤0.01%
+13,893
New +$253K
NNA
1273
DELISTED
Navios Maritime Acquisition Corporation
NNA
$266K ﹤0.01%
29,067
-11,000
-27% -$124K
VSTO
1274
DELISTED
Vista Outdoor Inc.
VSTO
$265K ﹤0.01%
+17,087
New +$274K
FTEK icon
1275
Fuel Tech
FTEK
$43.9M
$263K ﹤0.01%
243,128
+49,500
+26% +$61K

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.